Leverages Co., Ltd. has introduced ChannelTalk to its online medical consultation service, Levacli, as part of its efforts to improve customer support and make patient communication easier to manage. The AI-powered customer communication platform, developed by Channel Corporation, has been in operation since March 16, 2026.
The company is using a combination of ChannelTalk’s Workflow, AI Agent ALF, and Email features. Together, these bring inquiries from email, inquiry forms, and live chat into one place instead of handling them separately. Patients can also receive responses around the clock through AI, making it possible to get answers to common questions even outside business hours. This also reduces the amount of routine work handled by the support team.
Before introducing the platform, Levacli was dealing with a few ongoing issues. Customer inquiries were spread across different channels, making them difficult to manage. Traditional rule-based chatbots could only respond to predefined scenarios, and it was often difficult for the team to understand the actual reasons behind patient concerns.
こちらもお読みください: EM Systems社とGood Cycle Systems社が合併しました
AI Agent ALF approaches these conversations differently. Instead of relying on fixed conversation flows, it responds to free-text questions by referring to FAQs and the company’s internal knowledge base. That allows it to provide answers that are more relevant to each patient’s question without limiting the conversation to preset options.
The platform is also expected to help beyond answering inquiries. By using チャンネルトーク‘s analytics, Levacli can identify the questions patients ask most often and spot recurring issues that may require service improvements. The company expects this to increase the number of inquiries resolved through self-service, reduce waiting times for responses, and make online medical consultations more accessible for patients. At the same time, support staff will be able to spend more time assisting patients who need more detailed or complex help.


